Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation A Factor Not to Be Disregarded

Journal of the American College of Cardiology

Volumn 67, Issue 14, 2016, Pages 1753-1754

  Onat, Altan ^a   Şimşek, Bariş ^b   Akbaş, Tuǧba ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN E; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ATRIAL FIBRILLATION; ATTRIBUTABLE RISK; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; HEART FAILURE; HEART INFARCTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; LETTER; METABOLIC SYNDROME X; MICROALBUMINURIA; MORTALITY; OBESITY; PRIORITY JOURNAL; CAUSE OF DEATH; FEMALE; MALE; MYOCARDIAL INFARCTION;

ATRIAL FIBRILLATION; CAUSE OF DEATH; FEMALE; HEART FAILURE; HUMANS; MALE; MYOCARDIAL INFARCTION;

EID: 84962144642     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.11.072     Document Type: Letter

References (5)

1. R.A. Vermond, B.H. Geelhoed, N. Verweij, and et al. Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands J Am Coll Cardiol 66 2015 1000 1007
2. A. Onat, and G. Can Enhanced proinflammatory state and autoimmune activation: a breakthrough to understanding chronic diseases Curr Pharm Design 20 2014 575 584
3. A. Onat, M. AydIn, B. Köroǧlu, and et al. Statin therapy and increased coronary heart disease risk in primary prevention of people with enhanced low-grade inflammation Turk Klin J Cardiovasc Sci 26 2014 118 127
4. J.P. Corsetti, S.J. Bakker, C.E. Sparks, and et al. Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease in women with high levels of HDL cholesterol and C-reactive protein PLoS One 7 2012 e39110
5. S. Mora, A.O. Akinkuolie, R.K. Sandhu, and et al. Paradoxical association of lipoprotein measures with incident atrial fibrillation Circ Arrhythm Electrophysiol 7 2014 612 619